XERS Xeris Biopharma Holdings, Inc.
$7.45▼ -2.87%
Healthcare
Other
After hours
$7.45▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.60M
Avg Volume (10D) 1.49M
Key Metrics & Fundamentals
Market Cap
$1.36B
P/E Ratio
122.7
Div Yield
–%
52W Range
5.25 - 10.08
% vs 50 MA
-11.26%
% vs 200 MA
5.50%
RSI-14
29.8
MACD Histogram
-0.1400
Beta (1Y vs SPY)
0.80
Free Cash Flow
$8.05M
Gross Rev
$92.10M
Gross Profit
$79.59M
EBITDA
$9.84M
COGS
$12.51M
Operating Exp
$74.42M
Operating Income
$5.17M
EBIT
$5.17M
Pretax Income
-$31.10M
Net Income
-$31.10M
EPS (Diluted)
-0.18
Price & Volume History
Loading chart…
Recent News
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism
Business Wire · Sep 9, 2026 12:30 PM
Xeris Announces Details for XP-8121 Program Overview Webinar
Business Wire · Aug 26, 2026 11:30 AM
Why Xeris Biopharma Holdings (XERS) Is Up 8.4% After Tightening 2026 Revenue Guidance And Advancing XP-8121
Simply Wall St. · Aug 15, 2026 6:11 AM
Xeris Biopharma Holdings (XERS) Posts Record Q2 Revenue, Is It Still A Bargain?
Simply Wall St. · Aug 14, 2026 7:10 PM
Xeris (XERS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 4:15 PM
Xeris Biopharma Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 8:04 PM
Xeris Biopharma Holdings Inc (XERS) (Q2 2026) Earnings Call Highlights: Record Revenue and ...
GuruFocus.com · Aug 6, 2026 11:13 PM
Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics
Zacks · Aug 6, 2026 1:30 PM
Xeris Biopharma: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 11:18 AM
Xeris Biopharma Reports Second Quarter 2026 Financial Results
Business Wire · Aug 6, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See XERS's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.